Copyright
©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 103701
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103701
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103701
Figure 1 Process of participant screening.
Figure 2 Distribution of Brief Psychiatric Rating Scale total scores and subscale scores for first-episode schizophrenia at each visit.
BPRS: Brief Psychiatric Rating Scale.
Figure 3 Decrease in Brief Psychiatric Rating Scale total scores and negative symptoms subscale scores for prominent negative symp toms and non-prominent negative symptoms.
The decrease equals the pre-treatment score minus the post-treatment score at each visit. BPRS: Brief Psychiatric Rating Scale; PNS: Prominent negative symptoms.
- Citation: Chen LH, Guo Q, Hu Y, Liu XH, Hu H, Chen HY, Liu CP, Li HF, Chen JD, Li GJ. Effectiveness and safety of blonanserin monotherapy for first-episode schizophrenia with and without prominent negative symptoms: A prospective study. World J Psychiatry 2025; 15(5): 103701
- URL: https://www.wjgnet.com/2220-3206/full/v15/i5/103701.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i5.103701